Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 6,340 | 5,076 | 9,780 | 6,570 | 2,429 |
| Gross Profit | 6,340 | 5,076 | 9,780 | 6,570 | 2,429 |
| Operating Expenses | 15,736 | 13,355 | 16,030 | 14,860 | 8,373 |
| Operating Income | -9,396 | -8,279 | -6,250 | -8,290 | -5,944 |
| Other Income | 976 | 1,582 | 2,147 | 2,370 | 1,729 |
| Pre-tax Income | -8,420 | -6,697 | -4,103 | -5,920 | -4,215 |
| Net Income Continuous | -8,420 | -6,697 | -4,103 | -5,920 | -4,215 |
| Net Income | $-8,420 | $-6,697 | $-4,103 | $-5,920 | $-4,215 |
| EPS Basic Total Ops | -1,254.13 | -1,012.10 | -440.04 | -880.09 | -638.06 |
| EPS Basic Continuous Ops | -1,262.50 | -1,005.04 | -429.86 | -890.92 | -637.21 |
| EPS Diluted Total Ops | -1,254.13 | -1,012.10 | -440.04 | -880.09 | -638.06 |
| EPS Diluted Continuous Ops | -1,262.50 | -1,005.04 | -429.86 | -890.92 | -637.21 |
| EBITDA(a) | $-9,340 | $-8,235 | $-6,221 | $-8,262 | $-5,920 |